| 2025-01 |
Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models |
Pharmacological Research. 2025 Jan;211:Article number 107556. |
 |
| 2024-11-26 |
Development of potent and selective inhibitors of methylenetetrahydrofolate dehydrogenase 2 for targeting acute myeloid leukemia: Sar, structural insights, and biological characterization |
Journal of Medicinal Chemistry. 2024 Nov 26;67(23):21106-21125. |
|
| 2024-02-15 |
Aminothiazole compounds as protein kinase inhibitors |
MY-201291-A/2024-02-15 |
|
| 2023-04-19 |
Aminothiazole compounds as protein kinase inhibitors |
EP3638237/2023-04-19 |
|
| 2023-03-21 |
Aminothiazole compounds as protein kinase inhibitors |
CA3064081/2023-03-21 |
|
| 2022-10-21 |
氨基噻唑化合物及其用途 |
HK1258689/2022-10-21 |
|
| 2022-09-27 |
아미노티아졸 화합물 및 이의 용도 |
KR10-2449712/2022-09-27 |
|
| 2022-09-21 |
氨基噻唑化合物及其用途 |
J/006296/2022-09-21 |
|
| 2022-07-25 |
Aminothiazole compounds as protein kinase inhibitors |
IN101988/2022-07-25 |
|
| 2022-07-15 |
Compuestos de aminotiazol como inhibidores de la proteina quinasa |
MX393992/2022-07-15 |
|
| 2022-06-28 |
氨基噻唑化合物及其用途 |
CN109069504/2022-06-28 |
|
| 2022-05-23 |
Aminothiazole compounds as protein kinase inhibitors |
RU2772645/2022-05-23 |
|
| 2022-04-12 |
Thiazole compounds as protein kinase inhibitors |
US11299489/2022-04-12 |
|
| 2022-03-03 |
단백질 키나아제 억제제로서의 아미노티아졸 화합물 |
KR10-2372288/2022-03-03 |
|
| 2022-03-02 |
Aminothiazole compounds and use thereof |
EP3411035/2022-03-02 |
|
| 2021-12-21 |
噻唑化合物作為蛋白質激酶抑制劑 |
TWI750905/2021-12-21 |
|
| 2021-11-30 |
Aminothiazole compounds as protein kinase inhibitors |
NZ759327/2021-11-30 |
|
| 2021-11-18 |
プロテインキナーゼ阻害剤としてのアミノチアゾール化合物 |
JP6979595/2021-11-18 |
|
| 2021-10-07 |
Aminothiazole compounds as protein kinase inhibitors |
AU2018284249/2021-10-07 |
|
| 2021-08-12 |
Xanthine derivatives reveal an allosteric binding site in methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) |
Journal of Medicinal Chemistry. 2021 Aug 12;64(15):11288-11301. |
|
| 2021-08-01 |
DBPR108, a novel dipeptidyl peptidase-4 inhibitor with antihyperglycemic activity |
Life Sciences. 2021 Aug 1;278:Article number 119574. |
|
| 2021-05-11 |
アミノチアゾール化合物及びその使用 |
JP6883049/2021-05-11 |
|
| 2021-01 |
Potent and orally active purine-based fetal hemoglobin inducers for treating Beta-thalassemia and sickle cell disease |
European Journal of Medicinal Chemistry. 2021 Jan;209:Article number 112938. |
|
| 2020-12-23 |
Aminothiazole compounds as protein kinase inhibitors |
ZA202000107/2020-12-23 |
|
| 2019-12 |
Identification of a multitargeted tyrosine kinase inhibitor for the treatment of gastrointestinal stromal tumors and acute myeloid leukemia |
Journal of Medicinal Chemistry. 2019 Dec;62(24):11135-11150. |
|
| 2019-11-12 |
Composto |
PI0906094-4/2019-11-12 |
|
| 2019-08-01 |
作為蛋白激酶抑制劑的胺基噻唑化合物 |
TWI667236/2019-08-01 |
|
| 2019-07 |
Use of integrated genomic analyses in patient-derived tumor model to discover new clinical indications for the multikinase inhibitor drug candidate, DBPR216 |
Cancer Research. 2019 Jul;79(13, Suppl.):Abstract number 4626. |
|
| 2019-05-28 |
Identification of novel anti-liver cancer small molecules with better therapeutic index than sorafenib via zebrafish drug screening platform |
Cancers. 2019 May 28;11(6):Article number 739. |
|
| 2019-05-28 |
Aminothiazole compounds as protein kinase inhibitors |
US10300061/2019-05-28 |
|
| 2019-04-10 |
Discovery of Conformational Control Inhibitors Switching off the Activated c-KIT and Targeting a Broad Range of Clinically Relevant c-KIT Mutants |
Journal of Medicinal Chemistry. 2019 Apr 10;62(8):3940-3957. |
|
| 2018-08-24 |
BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor |
Cancer Science. 2018 Nov;109(11):3591-3601. |
|
| 2018-08-14 |
Aminothiazole compounds |
US10047078/2018-08-14 |
|
| 2018-04-11 |
氨基噻唑化合物及其用途 |
TWI620748/2018-04-11 |
|
| 2017-03-21 |
Pyrrolidine derivatives |
CA2717518/2017-03-21 |
|
| 2016-12 |
Novel cKIT kinase inhibitor, BPRCKJ001, as an advanced therapeutic candidate for GIST |
Annals of Oncology. 2016 Dec;27(Suppl. 9):Meeting Abstract 2P. |
|
| 2016-10 |
BPR1J373, an oral multiple tyrosine kinase inhibitor, targets c-KIT for the treatment of c-KIT driven myeloid leukemia |
Molecular Cancer Therapeutics. 2016 Oct;15(10):2323-2333. |
|
| 2016-08-30 |
Pyrrolidine derivatives |
IN275254/2016-08-30 |
|
| 2016-06-23 |
피롤리딘 유도체 |
KR10-1634656/2016-06-23 |
|
| 2016-04-12 |
Pyrazolylamine derivatives reveal the conformational switching between type I and type II binding modes of Anaplastic Lymphoma Kinase (ALK) |
Journal of Medicinal Chemistry. 2016 Apr 12;59(8):3906-3919. |
|
| 2016-02-09 |
Pyrazole compounds and thiazole compounds as protein kinases inhibitors |
US9255072/2016-02-09 |
|
| 2015-11-13 |
Pyrrolidine derivatives |
MY-155630-A/2015-11-13 |
|
| 2015-07 |
Identification of a potent 5-phenyl-thiazol-2-ylamine-based inhibitor of FLT3 with activity against drug resistance-conferring point mutations |
European Journal of Medicinal Chemistry. 2015 Jul;100:151-161. |
|
| 2014-08-01 |
Pyrrolidine derivatives |
JP5586484/2014-08-01 |
|
| 2014-05-12 |
Pyrrolidine derivatives |
J/001349/2014-05-12 |
|
| 2014-05-08 |
Pyrrolidine derivatives |
AU2009222198/2014-05-08 |
|
| 2014-04-25 |
Pyrrolidine derivatives |
HK1149261/2014-04-25 |
|
| 2014-04-21 |
作為蛋白質激酶抑制劑之吡唑化合物及噻唑化合物、其醫藥組成物及用途 |
TWI434834/2014-04-21 |
|
| 2014-02-19 |
Pyrrolidine derivatives |
EP2252582/2014-02-19 |
|
| 2014-02 |
Fibroblast activation protein (FAP) is essential for the migration of bone marrow mesenchymal stem cells through RhoA activation |
PLoS ONE. 2014 Feb 13;9(2):Article number e88772. |
|
